NextPlat Corp. (NASDAQ:NXPL – Get Free Report)’s stock price traded up 6.5% during mid-day trading on Thursday . The company traded as high as $8.37 and last traded at $7.69. 59,910 shares traded hands during trading, an increase of 205% from the average session volume of 19,660 shares. The stock had previously closed at $7.22.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings upgraded shares of NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, NextPlat currently has a consensus rating of “Sell”.
NextPlat Stock Performance
NextPlat (NASDAQ:NXPL – Get Free Report) last announced its earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share (EPS) for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.The business had revenue of $9.86 million for the quarter.
Institutional Trading of NextPlat
A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC purchased a new position in shares of NextPlat Corp. (NASDAQ:NXPL – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by institutional investors and hedge funds.
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Featured Articles
- Five stocks we like better than NextPlat
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
